FMO5 and diabetic kidney disease: And the specific mechanism may be to suppress inflammation and oxidative stress in HK-2 cells by inhibiting the NADPH/oxidase-TGF-β/Smad signaling pathway, thereby alleviating renal fibrosis and ultimately ameliorating early renal damage in DKD.